Malek B. Hannouf

Learn More
PURPOSE To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) from the perspective of the Canadian public healthcare system. METHODS We developed a Markov state transition model to project the lifetime clinical and(More)
  • 1